Athersys: A Significantly Undervalued Stem Cell Company Approaching Key Catalysts

I suggest investors take a look at an under-followed company called Athersys . After decades of debate on the ethics of stem cell research, the rhetoric has ebbed and focus has shifted from ethics to the promises of clinical development.

http://seekingalpha.com/article/1141481-athersys-a-significantly-undervalued-stem-cell-company-approaching-key-catalysts?source=feed